Daniel C. Martin - Net Worth and Insider Trading
Daniel C. Martin Net Worth
The estimated net worth of Daniel C. Martin is at least $1 Million dollars as of 2024-09-20. Daniel C. Martin is the Chief Commercial Officer of Deciphera Pharmaceuticals Inc and owns about 47,660 shares of Deciphera Pharmaceuticals Inc (DCPH) stock worth over $1 Million. Details can be seen in Daniel C. Martin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Daniel C. Martin has not made any transactions after 2024-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Daniel C. Martin
Daniel C. Martin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Daniel C. Martin owns 1 companies in total, including Deciphera Pharmaceuticals Inc (DCPH) .
Click here to see the complete history of Daniel C. Martin’s form 4 insider trades.
Insider Ownership Summary of Daniel C. Martin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
DCPH | Deciphera Pharmaceuticals Inc | 2024-01-16 | Chief Commercial Officer |
Daniel C. Martin Latest Holdings Summary
Daniel C. Martin currently owns a total of 1 stock. Daniel C. Martin owns 47,660 shares of Deciphera Pharmaceuticals Inc (DCPH) as of January 16, 2024, with a value of $1 Million.
Latest Holdings of Daniel C. Martin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
DCPH | Deciphera Pharmaceuticals Inc | 2024-01-16 | 47,660 | 25.59 | 1,219,619 |
Holding Weightings of Daniel C. Martin
Daniel C. Martin Form 4 Trading Tracker
According to the SEC Form 4 filings, Daniel C. Martin has made a total of 10 transactions in Deciphera Pharmaceuticals Inc (DCPH) over the past 5 years, including 0 buys and 10 sells. The most-recent trade in Deciphera Pharmaceuticals Inc is the sale of 1,624 shares on January 16, 2024, which brought Daniel C. Martin around $23,499.
Insider Trading History of Daniel C. Martin
- 1
Daniel C. Martin Trading Performance
Daniel C. Martin Ownership Network
Daniel C. Martin Owned Company Details
What does Deciphera Pharmaceuticals Inc do?
Who are the key executives at Deciphera Pharmaceuticals Inc?
Daniel C. Martin is the Chief Commercial Officer of Deciphera Pharmaceuticals Inc. Other key executives at Deciphera Pharmaceuticals Inc include EVP & Chief Medical Officer Matthew L Sherman , Chief Financial Officer Thomas Patrick Kelly , and SVP & Regulatory & Quality Jama Pitman .
Deciphera Pharmaceuticals Inc (DCPH) Insider Trades Summary
Over the past 18 months, Daniel C. Martin made 5 insider transaction in Deciphera Pharmaceuticals Inc (DCPH) with a net sale of 23,797. Other recent insider transactions involving Deciphera Pharmaceuticals Inc (DCPH) include a net sale of 12,184 shares made by Matthew L Sherman , a net sale of 9,198 shares made by Thomas Patrick Kelly , and a net sale of 5,931 shares made by Jama Pitman .
In summary, during the past 3 months, insiders sold 0 shares of Deciphera Pharmaceuticals Inc (DCPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 112,502 shares of Deciphera Pharmaceuticals Inc (DCPH) were sold and 21,000 shares were bought by its insiders, resulting in a net sale of 91,502 shares.
Deciphera Pharmaceuticals Inc (DCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Deciphera Pharmaceuticals Inc Insider Transactions
Daniel C. Martin Mailing Address
Above is the net worth, insider trading, and ownership report for Daniel C. Martin. You might contact Daniel C. Martin via mailing address: C/o Deciphera Pharmaceuticals, Inc., 200 Smith Street, Waltham Ma 02451.